CinCor Pharma to Present at Upcoming Jefferies London Healthcare Conference
CinCor Pharma announced its participation at the Jefferies London Healthcare Conference from November 15-17, 2022. The presentation is scheduled for November 16, 2022, at 5 PM GMT, at the Waldorf Hilton. CinCor will also engage in one-on-one investor meetings during the event. Founded in 2018, CinCor focuses on developing treatments for cardio-renal diseases, with its lead asset, baxdrostat, targeting hypertension and primary aldosteronism.
- None.
- None.
WALTHAM, Mass., Nov. 09, 2022 (GLOBE NEWSWIRE) -- CinCor Pharma, Inc. (NASDAQ: CINC) today announced that company management will participate at the Jefferies London Healthcare Conference taking place on November 15-17, 2022 in London, United Kingdom. The presentation information is below:
| Jefferies London Healthcare Conference | |
| Presentation: | Wednesday, November 16, 2022 at 5 PM GMT |
| Location: | Track 2 – Room, Adelphi 2, Ground Level at the Waldorf Hilton |
The CinCor management team will participate in one-on-one investor meetings during the event. Investors interested in meeting with CinCor at the conference should contact their Jefferies representative.
About CinCor
CinCor, founded in 2018, is a clinical-stage biopharmaceutical company with a mission to bring innovation to the pharmaceutical treatment of cardio-renal diseases. Its lead asset, baxdrostat, a highly selective, oral small molecule inhibitor of aldosterone synthase, is in clinical development for the treatment of hypertension and primary aldosteronism.
| Contacts: | Investors: | |
| Mike Kalb | Bob Yedid | |
| CinCor Pharma, Inc. | LifeSci Advisors | |
| EVP and CFO | ir@CinCor.com |
FAQ
What is the date of the Jefferies London Healthcare Conference for CinCor?
When is CinCor's presentation scheduled at the Jefferies Conference?
Where will CinCor present at the Jefferies London Healthcare Conference?
What is the focus of CinCor Pharma's research?
How can investors meet with CinCor at the conference?
